EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - … Journal of Women's …, 2013 - Taylor & Francis
Background Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …
被引用次数：22 相关文章
[HTML] europepmc.org

[HTML][HTML] EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - … Journal of Women's …, 2013 - europepmc.org
Background Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …

EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert… - … Journal of Women's …, 2013 - search.proquest.com
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …

EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - International Journal of …, 2013 - go.gale.com
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …
[PDF] psu.edu

[PDF][PDF] EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - International Journal of …, 2013 - Citeseer
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …
[HTML] nih.gov

[HTML][HTML] EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - … Journal of Women's …, 2013 - ncbi.nlm.nih.gov
Background Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …
[PDF] semanticscholar.org

[PDF][PDF] EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert… - … of Women's Health, 2013 - pdfs.semanticscholar.org
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …

EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert, M Lissy… - … Journal of Women's …, 2013 - dovepress.com
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …

EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert… - … journal of women's …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …
[PDF] researchgate.net

[PDF][PDF] EE-drospirenone-levomefolate calcium versus EE-drospirenone+ folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment …

K Diefenbach, D Trummer, F Ebert… - … Journal of Women's …, 2013 - researchgate.net
Background: Adequate folate supplementation in the periconceptional phase is
recommended to reduce the risk of neural tube defects. Oral contraceptives may provide a …